NO991097L - New procedures - Google Patents

New procedures

Info

Publication number
NO991097L
NO991097L NO991097A NO991097A NO991097L NO 991097 L NO991097 L NO 991097L NO 991097 A NO991097 A NO 991097A NO 991097 A NO991097 A NO 991097A NO 991097 L NO991097 L NO 991097L
Authority
NO
Norway
Prior art keywords
new procedures
new
procedures
idoxifene
new method
Prior art date
Application number
NO991097A
Other languages
Norwegian (no)
Other versions
NO991097D0 (en
Inventor
Jeremy N Bradbeer
Maxine Gowen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO991097L publication Critical patent/NO991097L/en
Publication of NO991097D0 publication Critical patent/NO991097D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Det beskrives en ny metode for behandling av osteoporose. Idoxifene er den foretrukne forbindelse.A new method of treating osteoporosis is described. The idoxifene is the preferred compound.

NO991097A 1996-09-06 1999-03-05 New procedures NO991097D0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24
PCT/US1997/015474 WO1998009519A1 (en) 1996-09-06 1997-09-03 Method of treating post menopausal diseases, including osteoporosis

Publications (2)

Publication Number Publication Date
NO991097L true NO991097L (en) 1999-03-05
NO991097D0 NO991097D0 (en) 1999-03-05

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
NO991097A NO991097D0 (en) 1996-09-06 1999-03-05 New procedures
NO991096A NO991096L (en) 1996-09-06 1999-03-05 New procedures

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO991096A NO991096L (en) 1996-09-06 1999-03-05 New procedures

Country Status (16)

Country Link
EP (2) EP0927029A4 (en)
JP (2) JP2002515046A (en)
KR (2) KR20000068473A (en)
CN (2) CN1236313A (en)
AR (1) AR008155A1 (en)
AU (2) AU4409797A (en)
BR (2) BR9711676A (en)
CA (2) CA2264943A1 (en)
CO (2) CO5070658A1 (en)
CZ (1) CZ76699A3 (en)
IL (1) IL128645A0 (en)
NO (2) NO991097D0 (en)
PL (2) PL332278A1 (en)
TR (2) TR199900506T2 (en)
TW (1) TW411273B (en)
WO (2) WO1998009619A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5749998A (en) * 1997-02-11 1998-08-26 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (en) * 1999-02-12 2000-08-17 Stefan Neubauer Use of estrogens to treat cardiac insufficiency and left ventricular dysfunction following myocardial infarction
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
TWI303990B (en) 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2196003A (en) * 1986-09-11 1988-04-20 Nat Res Dev Iodo-and bromo-tamoxifen derivatives
ES2112994T3 (en) * 1992-09-15 1998-04-16 Merrell Pharma Inc NON METABOLIZABLE ANALOGS OF CLOMIFENE USED IN THE TREATMENT OF TAMOXIFENO RESISTANT TUMORS.
US6197789B1 (en) * 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
TW411273B (en) 2000-11-11
WO1998009619A1 (en) 1998-03-12
AR008155A1 (en) 1999-12-09
PL332278A1 (en) 1999-08-30
JP2002515047A (en) 2002-05-21
TR199900504T2 (en) 1999-06-21
WO1998009519A1 (en) 1998-03-12
KR20000068473A (en) 2000-11-25
JP2002515046A (en) 2002-05-21
CO4920218A1 (en) 2000-05-29
CO5070658A1 (en) 2001-08-28
CN1236299A (en) 1999-11-24
NO991097D0 (en) 1999-03-05
AU4247397A (en) 1998-03-26
NO991096D0 (en) 1999-03-05
BR9711676A (en) 1999-08-24
EP0927029A4 (en) 2001-06-13
NO991096L (en) 1999-03-05
CA2264943A1 (en) 1998-03-12
EP0929216A4 (en) 2001-04-04
CN1236313A (en) 1999-11-24
EP0927029A1 (en) 1999-07-07
EP0929216A1 (en) 1999-07-21
CZ76699A3 (en) 1999-08-11
CA2264775A1 (en) 1998-03-12
IL128645A0 (en) 2000-01-31
PL332038A1 (en) 1999-08-16
AU4409797A (en) 1998-03-26
BR9711681A (en) 1999-08-24
KR20000068472A (en) 2000-11-25
TR199900506T2 (en) 1999-07-21

Similar Documents

Publication Publication Date Title
ATE307119T1 (en) BICYCLIC PROTEIN FARNESYL TRANSFERASE INHIBITORS
ES2145915T3 (en) STEREOCHEMICAL DERIVATIVES OF WORTMANNINA.
ES2172587T3 (en) COMPOSITION THAT INCLUDES MORPHINE, POLYPIRROLIDONE AND ALKYLENE POLY-OXIDE.
EA199700170A1 (en) A METHOD OF OBTAINING SOME AZACYCLOHEXAPETIDES
SE9103612D0 (en) NEW PEPTIDE DERIVATIVES
EA199700061A1 (en) METHOD OF OBTAINING SILDENAFIL
DE69737689D1 (en) USE OF PYRIDAZINONE OR PHOSPHINOXIDE COMPOUNDS FOR THE TREATMENT OF HERZARRHYTHMIA
NO993247D0 (en) Process for the preparation of tolterodine
TR199801752T2 (en) Wood preservative for advanced protection.
MX9602861A (en) Synergistic stabilizing mixture.
NO991097L (en) New procedures
NO901383L (en) MACHINE FOR AUTOMATICALLY APPLICATION OF SOFT Gasket.
NO984245D0 (en) Nasal administration of agents for the treatment of late onset emesis
NO20000961L (en) New tissue-specific calpains, as well as methods of preparation and use thereof
NO973366L (en) Procedure for the treatment of multiple sclerosis
BR9906803A (en) Copd treatment process
EA199700439A1 (en) APPLICATION OF PYRROLIDINE DERIVATIVES FOR TREATING ALCOHOLISM
NO990436L (en) Procedure for the treatment of bipolar disorder
TR199900016T2 (en) Benzo $g] quinoline t�revleri.
NO985929L (en) New forms of organic salts of N'N-diacetylcystine
ES2156868T3 (en) ARILALCOXIFENOXI-IMIDAZOLINE COMPOUNDS.
SE8402505L (en) DEVICE FOR EQUIPMENT LIMITATION OF A MANOVER VALVE
UY24621A1 (en) NEW COMPOUNDS
NO954115L (en) Use of ceruletide-diethylamine salt in the treatment of psoriasis
SE8402656L (en) ADDITION DEVICE FOR NETWORKS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application